Wells Fargo lowered the firm’s price target on Bath & Body Works to $25 from $33 and keeps an Overweight rating on the shares. The firm says the anticipated reset to numbers finally happened. Bears will continue to argue for further downside. However, with Q4 guided down and called out several times as “the floor” on fundamentals, Wells sees 2026 as de-risked, with setup much more compelling.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body downgraded to Market Perform from Outperform at Telsey Advisory
- Bath & Body Works price target lowered to $18 from $28 at Barclays
- Challenges Ahead: Bath & Body Works Faces Structural Headwinds and Downgrade
- Bath & Body Works downgraded to Equal Weight from Overweight at Morgan Stanley
- Bath & Body Works Unveils Strategic Growth Plan